Surveillance of meningococcal infections in Belgium

Clinical Microbiology and Infection

Volumn 4, Issue 4, 1998, Pages 224-228

  Van Looveren, M ^a   Carion, F ^a   Vandamme, P ^a   Goossens, H ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CEFTRIAXONE; CIPROFLOXACIN; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; PENICILLIN G; RIFAMPICIN; SULFADIAZINE;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIUM ISOLATION; BELGIUM; CHILD; FEMALE; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA MENINGITIDIS; NETHERLANDS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPING;

BACTERIA (MICROORGANISMS); NEISSERIA MENINGITIDIS;

EID: 0031901027     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1998.tb00675.x     Document Type: Article

References (22)

1. Guibourdenche M, HØiby EA, Riou JY, Variane F, Joguet C, Cangant DA. Epidemics of serogroup A Neisseria meningitidis of subgroup III in Africa, 1989-94. Epidemiol Infect 1996; 116: 115-20.
2. Ringuette L, Lorange M, Ryan A, Ashton F. Meningococcal infections in the province of Québec, Canada, during the period 1991 to 1992 J Clin Microbiol 1995; 33: 53-7.
3. Frasch CE, Zollinger WD, Poolman JT. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serorypes. Rev Infect Dis 1985; 7: 504-10.
4. Romero JD, Outschoorn IM. Current status of meningococcal group B vaccine candidates: capsular or noncapsular? Clin Microbiol Rev 1994; 7: 559-75.
5. Blondeau JM, Ashton FE, Isaacson M, Yaschuk Y, Anderson C, Ducasse G. Neisseria meningitidis with decreased susceptibility to penicillin in Saskatchewan, Canada. J Clin Microbiol 1995; 33: 1784-6.
6. Campos J, Trujillo G, Seuba T, Rodriguez A. Discriminative criteria for Neisseria meningitidis isolates that are moderately susceptible to penicillin and ampicillin. Antimicrob Agents Chemother 1992; 5: 1028-31.
7. Scholten RJPM, Bijlmer HA, Poolman JT, et al. Meningococcal disease in the Netherlands, 1958-1990: a steady increase of the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis. Clin Infect Dis 1993; 16: 237-46
8. Van Looveren M, Vandamme P, Hauchecorne M, et al. Molecular epidemiology of recent Belgian isolates of Neisseria meningitidis serogroup B. Submitted.
9. Carion F. Meningococci: Surveillance in Belgium by the reference laboratory. In: Program and abstracts of the 11th Seminar on Diagnostics and Surveillance of Infectious Diseases. Brussels, Belgium. Institute of Hygiene and Epidemiology, 1995: 21-9.
10. Riou JY, Saliou P, Guibourdenche M, Chalvignac MA. Etude bactériologique et sérologique de 358 souches de Neisseria et Branhamella isolées en Haute-Volta. Med Mal Infect 1980; 10: 430-6.
11. Calain P, Poolman J, Zollinger W, et al. Serological study of meningococcal isolates in Switzerland and France 1980-1986. Eur J Clin Microbiol Infect Dis 1988; 7: 788-91.
12. Abdillahi H, Poolman JT Whole-cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol Lett 1987; 48: 367-71.
13. De Maeyer S, Seba JM, Reginster G. Epidemiology of meningococcal meningitis in Belgium. J Infect 1981; 3(suppl 1): 63-70.
14. Caugant DA, Bol P, HØiby EA, Zanen HC, FrØholm LO. Clones of serogroup B Neisseria meningitidis causing systemic disease in the Netherlands, 1958-1986. J Infect Dis 1990; 162: 867-74.
15. Kaczmarski EB. Meningococcal disease in England and Wales: 1995. CDR Rev 1997; 7: R55-9.
16. Hughes JH, Bredenbach DJ, Erwin ME. Jones RN. E-test as susceptibility test and epidemiologic tool for evaluation of Neisseria meningitidis isolates. J Clin Microbiol 1993; 31: 3255-9.
17. Blondeau JM, Yaschuk Y. In vitro activities of ciprofioxacin, cefotaxime, ceftriaxone, chloramphemcol, and rifampin against fully susceptible and moderately penicillin-resistant Neisseria meningitidis. Andmicrob Agents Chemother 1995; 39: 2577-9.
18. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M100-S6. Villanova, PA: NCCLS, 1997.
19. Sutcliffe EM, Jones DM, El-Sheikh S, Percival A. Penicillin-insensitive meningococci in the UK. Lancet 1988; i: 657-8.
20. Sáez-Nieto JA, Lujan R, Berrón S, et al. Epidemiology and molecular basis of penicillin-resistant Neisseria meningitidis in Spain: a 5-year history (1985-1989). Clin Infect Dis 1992; 14: 394-402.
21. Jackson LA, Tenover FC, Baker C, et al. Prevalence of Neisseria meningitidis relatively resistant to penicillin in the United States, 1991. J Infect Dis 1994; 169: 438-41.
22. Brunen A, Peetermans W, Verhaegen J, Robberecht W. Meningitis due to Neisseria meningitidis with intermediate susceptibility to penicilin. Eur J Clin Microbiol Infect Dis 1993; 12: 969-70.